Cetirizine, a histamine H1 receptor antagonist currently used to relieve allergies [46], and paroxetine, a serotonin reuptake transport inhibitor and GRK2 inhibitor prescribed for depression [47], were further evaluated for their capacity to reduce JCPyV infection in primary cells. This evidence concerns the gene GRK2 and allergic disease.